PharmaNordic ApS: Financial statements 2022
CVR: 36408464
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
PharmaNordic ApS (CVR 36408464) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 574,645 and a net result of DKK 183,286 compared with DKK 144,394 the year before. That is a decrease of 22.2% compared with the year before. Equity in the 2022 report amounted to DKK 673,183. The solvency ratio was 70.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 574,645
- Profit/Loss
- DKK 183,286
- Equity
- DKK 673,183
- Total Assets
- DKK 949,210
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 575 t. | 183 t. | 673 t. | 1 |
| 2021 | - | 738 t. | 144 t. | 490 t. | - |
| 2020 | - | 517 t. | 574 t. | 346 t. | - |
| 2019 | - | 289 t. | -88 t. | -229 t. | - |
| 2018 | - | 476 t. | 109 t. | -141 t. | - |
Official annual report
Keep an eye on PharmaNordic ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
PharmaNordic ApS has published its annual report for 2021. Gross profit came to DKK 738,342, and the net result was DKK 144,394.
About PharmaNordic ApS
PharmaNordic ApS is a Danish company of the type Anpartsselskab based in Greve, founded in 2014. The company is registered under the industry Planlægning og design af reklamekampagner. The management consists of Anders Lentini From. The company is owned by LENTINI HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK -197,662 and a net result of DKK 2,313,695 compared with DKK 647,775 the year before. Equity in the 2025 report amounted to DKK 4,025,013.